Acne Therapeutics Market Size (2024 - 2029)

The acne therapeutics market is projected to experience growth over the forecast period, driven by factors such as increasing sedentary lifestyles, rising disposable incomes, and heightened awareness of acne treatment options. The market's expansion is further supported by the relaxation of pandemic-related restrictions, which has led to a resurgence in patient visits to dermatology clinics. Despite challenges such as safety concerns related to acne products and the introduction of generic alternatives, the market is expected to grow due to the high prevalence of acne globally and ongoing educational campaigns about new treatments.

Market Size of Acne Therapeutics Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Acne Therapeutics Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 8.64 Billion
Market Size (2029) USD 10.98 Billion
CAGR (2024 - 2029) 4.89 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Acne Therapeutics Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Acne Therapeutics Market Analysis

The Acne Therapeutics Market size is estimated at USD 8.64 billion in 2024, and is expected to reach USD 10.98 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

COVID-19 significantly impacted the growth of the market during the pandemic period. The strict regulations imposed by government organizations led to a decline in patient visits to dermatology hospitals and clinics. For instance, an NCBI study published in November 2021 in the National Library of Medicine reported decreased patient volume capacity in dermatology clinics, fewer aesthetic procedures, and an increase in the use of virtual medicine by board-certified North American dermatologists. However, the relaxation of strict lockdown regulation in the post-pandemic period leading to an increase in the patient inflow to dermatology clinics is expected to drive the market growth in the forecast period.

The key factors propelling the growth of the acne therapeutics market are increasing sedentary lifestyles, the rise in disposable income of consumers, rising awareness about upcoming trends in acne treatments, and the high prevalence of acne globally.

Acne is the most common skin condition affecting late adolescents across the world. Acne vulgaris is a common heath problem affecting adolescents with a considerable impact on their quality of life. For instance, the data published by ClickPharmacy in May 2022 reported that 34% of United Kingdom adults have suffered from acne at some point in their life. The same source mentioned that 6.1% of men are currently suffering from acne when compared to 2.5% of women in 2022. Also, the article published by Sahel Medical Journal in March 2021, mentioned that the prevalence of acne vulgaris in South Nigeria was 37.3% with high prevalence in females (37.6%) than in males (36.7%). Thus, the rising incidence of acne will lead to increased adoption of acne therapeutics, thereby driving the market's growth.

Furthermore, in March 2021, Galderma launched a new digital campaign. "Me Being Me" for topical acne treatment with Aklief (trifarotene) Cream. The company spent much of the year educating patients about Aklief, which is the first new retinoid molecule to gain approval for acne vulgaris in more than 20 years. Such initiatives provide insight into the upcoming treatment for acne. These campaigns increase the growth of the market during the forecast period.

Thus, the high prevalence of acne among the global population and the rise in awareness of acne treatment is expected to drive the market during the forecast period. However, safety issues related to acne products and the entry of generics into the acne market are expected to hinder market growth.

Acne Therapeutics Industry Segmentation

As per the scope of the report, acne is a chronic inflammatory skin disease commonly affecting adolescent and adult populations. Abnormal hormone production is found to be the key causative factor. Acne therapeutics include several prescriptions and over-the-counter medicines, such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives. The Acne Therapeutics Market is segmented by Treatment (Therapeutics (Retinoid, Antibiotics, Hormonal Agents, Anti-inflammatory and Other Agents) and Other Treatments), Route of Administration (Oral and Topical), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

By Treatment
Therapeutics
Retinoid
Antibiotics
Hormonal Agents
Anti-inflammatory
Other Agents
Other Treatments
By Route of Administration
Oral
Topical
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Acne Therapeutics Market Size Summary

The acne therapeutics market is poised for significant growth over the forecast period, driven by increasing sedentary lifestyles, rising disposable incomes, and heightened awareness of acne treatment options. The market's expansion is further supported by the high prevalence of acne, particularly among adolescents, which underscores the demand for effective therapeutic solutions. The post-pandemic recovery, marked by increased patient visits to dermatology clinics, is expected to bolster market growth. Key players in the industry are actively engaging in product development and digital campaigns to educate consumers about new treatments, such as Galderma's "Me Being Me" campaign for Aklief. Despite challenges such as safety concerns and the entry of generics, the market is expected to thrive, with retinoids playing a pivotal role due to their effectiveness in treating and maintaining clear skin.

North America is anticipated to hold a significant share of the acne therapeutics market, driven by the presence of major market players and a high burden of acne in the region. The frequent product launches and approvals, such as Cutera's AviClear and Sun Pharmaceuticals' Winlevi, are expected to propel market growth. The competitive landscape is characterized by the presence of both major and local players, with companies like Abbvie Inc., Johnson & Johnson, and L'Oréal S.A. actively developing novel products and technologies. Collaborative efforts and strategic expansions, such as Sun Pharmaceuticals' territory expansion in Mexico, further highlight the dynamic nature of the market. Overall, the combination of innovative product offerings, strategic partnerships, and a growing understanding of acne treatment is set to drive the market forward.

Explore More

Acne Therapeutics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Sedentary Lifestyle and Unhealthy Food Habits

      2. 1.2.2 Increasing Awareness About Current and Upcoming Acne Treatments

      3. 1.2.3 High Global Acne Prevalence

    3. 1.3 Market Restraints

      1. 1.3.1 Safety Issues Regarding the Products

      2. 1.3.2 Entry of Generics in the Market

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Treatment

      1. 2.1.1 Therapeutics

        1. 2.1.1.1 Retinoid

        2. 2.1.1.2 Antibiotics

        3. 2.1.1.3 Hormonal Agents

        4. 2.1.1.4 Anti-inflammatory

        5. 2.1.1.5 Other Agents

      2. 2.1.2 Other Treatments

    2. 2.2 By Route of Administration

      1. 2.2.1 Oral

      2. 2.2.2 Topical

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Acne Therapeutics Market Size FAQs

The Acne Therapeutics Market size is expected to reach USD 8.64 billion in 2024 and grow at a CAGR of 4.89% to reach USD 10.98 billion by 2029.

In 2024, the Acne Therapeutics Market size is expected to reach USD 8.64 billion.

Acne Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)